Lilly Zyprexa, Symbyax Labeling Strengthened
This article was originally published in The Pink Sheet Daily
Executive Summary
Update elevates information on weight gain and hyperlipidemia from adverse event precaution to “Warning” status and adds to elevated blood sugar warning.